The Efficacy and Safety of Huaiqihuang Granule in Children With Chronic Primary Immune Thrombocytopenia

NCT03201848 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

216

Enrollment

INDUSTRY

Sponsor class

Conditions

Immune Thrombocytopenia

Interventions

DRUG: Placebo
DRUG: Huaiqihuang Granule

Sponsor

Qidong Gaitianli Medicines Co., Ltd

Collaborators

[object Object]